The Role of Apelin-APJ System in Diabetes and Obesity

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2022 Mar 31

PMID 35355561

Authors

Cheng Li

Hongna Cheng

Binay Kumar Adhikari

Shudong Wang

Na Yang

Wenyun Liu

Jian Sun

Yonggang Wang

Affiliations

Soon will be listed here.

Abstract

Nowadays, diabetes and obesity are two main health-threatening metabolic disorders in the world, which increase the risk for many chronic diseases. Apelin, a peptide hormone, exerts its effect by binding with angiotensin II protein J receptor (APJ) and is considered to be linked with diabetes and obesity. Apelin and its receptor are widely present in the body and are involved in many physiological processes, such as glucose and lipid metabolism, homeostasis, endocrine response to stress, and angiogenesis. In this review, we summarize the literatures on the role of the Apelin-APJ system in diabetes and obesity for a better understanding of the mechanism and function of apelin and its receptor in the pathophysiology of diseases that may contribute to the development of new therapies.

Citing Articles

A Novel Insight into the Role of Obesity-Related Adipokines in Ovarian Cancer-State-of-the-Art Review and Future Perspectives.

Kolakowska K, Kisluk J, Niklinski J Int J Mol Sci. 2025; 26(5).

PMID: 40076482 PMC: 11900017. DOI: 10.3390/ijms26051857.

Adipokines regulate the development and progression of MASLD through organellar oxidative stress.

Zhao K, Zhang H, Ding W, Yu X, Hou Y, Liu X Hepatol Commun. 2025; 9(2).

PMID: 39878681 PMC: 11781772. DOI: 10.1097/HC9.0000000000000639.

Exploring the Molecular Modalities in the Pathogenesis of Diabetic Kidney Disease with a Focus on the Potential Therapeutic Implications.

Gaydarski L, Petrova K, Angushev I, Stanchev S, Iliev A, Stamenov N Biomedicines. 2025; 13(1).

PMID: 39857634 PMC: 11763324. DOI: 10.3390/biomedicines13010050.

Structural insights into the regulation of monomeric and dimeric apelin receptor.

Yue Y, Liu L, Wu L, Xu C, Na M, Liu S Nat Commun. 2025; 16(1):310.

PMID: 39747115 PMC: 11697037. DOI: 10.1038/s41467-024-55555-6.

Proprotein convertase subtilisin/kexin type 9 and apelin in fibromyalgia syndrome.

Pihtili Tas N, Baykara R, Kamanli A, Gurbuz A, Cure E, Cumhur Cure M Arch Rheumatol. 2024; 39(3):375-383.

PMID: 39507838 PMC: 11537681. DOI: 10.46497/ArchRheumatol.2024.10462.

References

Rikitake Y . The apelin/APJ system in the regulation of vascular tone: friend or foe?. J Biochem. 2020; 169(4):383-386. DOI: 10.1093/jb/mvaa129. View

Lee D, Saldivia V, Nguyen T, Cheng R, George S, ODowd B . Modification of the terminal residue of apelin-13 antagonizes its hypotensive action. Endocrinology. 2004; 146(1):231-6. DOI: 10.1210/en.2004-0359. View

Charo D, Ho M, Fajardo G, Kawana M, Kundu R, Sheikh A . Endogenous regulation of cardiovascular function by apelin-APJ. Am J Physiol Heart Circ Physiol. 2009; 297(5):H1904-13. PMC: 2781363. DOI: 10.1152/ajpheart.00686.2009. View

Ni T, Lin N, Huang X, Lu W, Sun Z, Zhang J . Icariin Ameliorates Diabetic Cardiomyopathy Through Apelin/Sirt3 Signalling to Improve Mitochondrial Dysfunction. Front Pharmacol. 2020; 11:256. PMC: 7106769. DOI: 10.3389/fphar.2020.00256. View

Cavallo M, Sentinelli F, Barchetta I, Costantino C, Incani M, Perra L . Altered glucose homeostasis is associated with increased serum apelin levels in type 2 diabetes mellitus. PLoS One. 2012; 7(12):e51236. PMC: 3515542. DOI: 10.1371/journal.pone.0051236. View

Day R, Cavaglieri R, Feliers D . Apelin retards the progression of diabetic nephropathy. Am J Physiol Renal Physiol. 2013; 304(6):F788-800. PMC: 3602700. DOI: 10.1152/ajprenal.00306.2012. View

Chng S, Ho L, Tian J, Reversade B . ELABELA: a hormone essential for heart development signals via the apelin receptor. Dev Cell. 2013; 27(6):672-80. DOI: 10.1016/j.devcel.2013.11.002. View

Chapman N, Dupre D, Rainey J . The apelin receptor: physiology, pathology, cell signalling, and ligand modulation of a peptide-activated class A GPCR. Biochem Cell Biol. 2014; 92(6):431-40. PMC: 4894813. DOI: 10.1139/bcb-2014-0072. View

El Messari S, Iturrioz X, Fassot C, De Mota N, Roesch D, Llorens-Cortes C . Functional dissociation of apelin receptor signaling and endocytosis: implications for the effects of apelin on arterial blood pressure. J Neurochem. 2004; 90(6):1290-301. DOI: 10.1111/j.1471-4159.2004.02591.x. View

10.

Li B, Yin J, Chang J, Zhang J, Wang Y, Huang H . Apelin/APJ relieve diabetic cardiomyopathy by reducing microvascular dysfunction. J Endocrinol. 2021; 249(1):1-18. PMC: 8052525. DOI: 10.1530/JOE-20-0398. View

11.

Chen H, Zheng C, Zhang X, Li J, Li J, Zheng L . Apelin alleviates diabetes-associated endoplasmic reticulum stress in the pancreas of Akita mice. Peptides. 2011; 32(8):1634-9. DOI: 10.1016/j.peptides.2011.06.025. View

12.

Ringstrom C, Nitert M, Bennet H, Fex M, Valet P, Rehfeld J . Apelin is a novel islet peptide. Regul Pept. 2010; 162(1-3):44-51. DOI: 10.1016/j.regpep.2010.03.005. View

13.

Drougard A, Duparc T, Brenachot X, Carneiro L, Gouaze A, Fournel A . Hypothalamic apelin/reactive oxygen species signaling controls hepatic glucose metabolism in the onset of diabetes. Antioxid Redox Signal. 2013; 20(4):557-73. PMC: 3901354. DOI: 10.1089/ars.2013.5182. View

14.

Oharte F, Parthsarathy V, Flatt P . Chronic apelin analogue administration is more effective than established incretin therapies for alleviating metabolic dysfunction in diabetic db/db mice. Mol Cell Endocrinol. 2020; 504:110695. DOI: 10.1016/j.mce.2019.110695. View

15.

Huang Z, Wu L, Chen L . Apelin/APJ system: A novel potential therapy target for kidney disease. J Cell Physiol. 2017; 233(5):3892-3900. DOI: 10.1002/jcp.26144. View

16.

Antushevich H, Wojcik M . Review: Apelin in disease. Clin Chim Acta. 2018; 483:241-248. DOI: 10.1016/j.cca.2018.05.012. View

17.

Dray C, Knauf C, Daviaud D, Waget A, Boucher J, Buleon M . Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab. 2008; 8(5):437-45. DOI: 10.1016/j.cmet.2008.10.003. View

18.

OCarroll A, Lolait S, Harris L, Pope G . The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis. J Endocrinol. 2013; 219(1):R13-35. DOI: 10.1530/JOE-13-0227. View

19.

De Hert E, Bracke A, Pintelon I, Janssens E, Lambeir A, Van der Veken P . Prolyl Carboxypeptidase Mediates the C-Terminal Cleavage of (Pyr)-Apelin-13 in Human Umbilical Vein and Aortic Endothelial Cells. Int J Mol Sci. 2021; 22(13). PMC: 8268575. DOI: 10.3390/ijms22136698. View

20.

Janssens P, Decuypere J, Bammens B, Llorens-Cortes C, Vennekens R, Mekahli D . The emerging role of the apelinergic system in kidney physiology and disease. Nephrol Dial Transplant. 2021; 37(12):2314-2326. DOI: 10.1093/ndt/gfab070. View